An upcoming offering of 5.3 million shares by company shareholders has been announced by Nexeon Medsystems, a Dallas-based developer of neurostimulation devices. Nexeon will receive the warrants' exercise price but will not obtain any proceeds from the sale of shares.
Nexeon Medsystems announces shareholder offering of 5.3M shares
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.